Premium
Evidence‐based management of patients undergoing PCI: Contrast‐induced acute kidney injury
Author(s) -
Caixeta Adriano,
Mehran Roxana
Publication year - 2010
Publication title -
catheterization and cardiovascular interventions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.988
H-Index - 116
eISSN - 1522-726X
pISSN - 1522-1946
DOI - 10.1002/ccd.22376
Subject(s) - medicine , acute kidney injury , nephrotoxicity , intensive care medicine , diabetes mellitus , conventional pci , heart failure , contrast (vision) , cardiology , kidney , myocardial infarction , artificial intelligence , computer science , endocrinology
Contrast‐induced acute kidney injury (CI‐AKI) is one of the leading causes of hospital‐acquired acute kidney injury. CI‐AKI is highly prevalent in patients with well‐known risk factors, including older age, chronic renal insufficiency, congestive heart failure, and diabetes. Thus far, no strategies have been shown to be effective in preventing CI‐AKI beyond thorough patient selection, minimizing the amount of contrast agent, and meticulous hydration of the patient. The role of various drugs in preventing CI‐AKI is still controversial and warrants future studies. Despite the remaining uncertainty regarding the degree of nephrotoxicity produced by various contrast agents, nonionic low‐osmolar contrast media may be preferred in patients at high risk for CI‐AKI. © 2010 Wiley‐Liss, Inc.